BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:Central Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:Central Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20250128T150000
DTEND;TZID=America/Chicago:20250128T160000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Alpha Cognition ZUNVEYL™ Q1 2025 Launch Strategy
DESCRIPTION:Join Alpha Cognition as they present their commercial launch strategy for ZUNVEYL (benzgalantamine)\, an FDA-approved treatment for mild-to-moderate Alzheimer's disease (AD). The call will focus on the company's plans to address the needs of a growing patient population within the $2 billion long-term care market in the U.S.
X-ALT-DESC;FMTTYPE=text/html:Join Alpha Cognition as they present their commercial launch strategy for ZUNVEYL (benzgalantamine)\, an FDA-approved treatment for mild-to-moderate Alzheimer&rsquo\;s disease (AD). The call will focus on the company&rsquo\;s plans to address the needs of a growing patient population within the $2 billion long-term care market in the U.S.
LOCATION:
UID:e.3812.1113208
SEQUENCE:3
DTSTAMP:20260503T115803Z
URL:https://biontx.growthzoneapp.com/biontx-event-calendar/Details/alpha-cognition-zunveyl-q1-2025-launch-strategy-1291683?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR